Lead Story Picture
After five hours of deliberation, the jury found that Hospira infringed Amgen's patent that covers the creation of specialized erythropoietin protein cells, or EPO, that stimulate the creation of red blood cells in anemia patients. (AP)

Amgen Gets $70M In Biosimilar Patent Suit Against Hospira

A Delaware federal jury awarded Amgen Inc. $70 million in damages late Friday after finding that Hospira Inc. infringed a patent for the anemia treatment Epogen, rejecting Hospira's argument that it was protected by a safe harbor meant for companies seeking federal approval for biosimilar products.

  • Trump's Latest US Atty Noms Include Sidley, Goodwin Alums

    President Donald Trump released on Friday his latest batch of nominations for U.S. attorney, including former associates at Sidley Austin LLP and Goodwin Procter LLP.

  • Aegerion To Pay $40M To End Host Of Juxtapid Claims

    Massachusetts-based biopharmaceutical company Aegerion Pharmaceuticals Inc. agreed Friday to pay about $40 million to end criminal and civil allegations by the U.S. Department of Justice and fraud charges brought by the U.S. Securities and Exchange Commission over an expensive cholesterol treatment.

  • BofA, Merrill Unit Pay $5M To Settle 'Pre-Hedging' Probes

    Bank of America Corp. and its Merrill Lynch Pierce Fenner & Smith Inc. broker-dealer unit agreed to pay a total of $5 million to settle allegations they misled prosecutors and regulators investigating former New York swaps traders for executing futures trades after learning big trades were in the pipeline, federal authorities announced Friday.

  • Burger King Can't Pause Receipt Suit Pending Dismissal Bid

    A Florida federal judge on Friday rejected Burger King’s bid to pause a proposed class action accusing it of printing too many card digits on receipts, saying the likelihood of the restaurant succeeding in its bid to ax the suit isn’t so high that he needs to impose a stay while deciding the motion.

  • Michael Jackson's Co. Can't Shrink Quincy Jones’ $9.4M Win

    A California judge Friday rebuffed a bid by Michael Jackson’s production company to slash a jury’s $9.4 million royalty damages award to Quincy Jones for work on the albums "Thriller," "Bad" and "Off the Wall," rejecting arguments that Jones’ main claims weren’t supported by trial evidence.

  • Judge Can’t File Brief In Patent Case Venue Row: Fed. Circ.

    The Federal Circuit on Friday denied a request from a district court judge who wanted to respond to an appeal of his decision to keep a patent lawsuit against Micron Inc. in Massachusetts following the U.S. Supreme Court’s recent TC Heartland ruling.

  • Calif. Panel Says Real Estate Atty Was Wrongly DQ'd

    A California appeals court reversed on Thursday a trial court's decision to disqualify Spainhour Law Group from defending Real Estate Portfolio Management LLC and its owner against a suit filed by another real estate company over an allegedly breached partnership agreement.

  • TGI Friday's Must Rework $19.1M Wage Deal, Judge Says

    A New York federal judge on Thursday rejected a proposed $19.1 million settlement between a putative class of 28,800 TGI Friday's tipped workers and the restaurant chain, saying it contains confidentiality and release provisions that could not “pass muster.”

  • McCain Opposes ACA Repeal, Imperiling Bill

    Sen. John McCain, R-Ariz., may have derailed the latest attempt to repeal and replace the Affordable Care Act, issuing a statement Friday saying he would not support the bill for its rushed nature and lack of independent analysis.

  • Facebook Drops Nonvoting Stock Plan, Trial Is Canceled

    Facebook dropped its plans Friday to create a nonvoting class of stock that would have allowed CEO Mark Zuckerberg to retain control of the company while divesting 99 percent of his stake to charity, an about-face that scotched a Delaware Chancery Court trial scheduled for next week.

  • Meningitis Pharmacist Shrugged Off Safety Rules, Jury Told

    A pharmacy technician told a federal jury Friday that his boss told him to fake documents, skip safety tests and use expired ingredients at a Massachusetts pharmacy linked to the 2012 fatal meningitis outbreak.

  • Walgreens, Benefits Manager Hit With $1.5B Antitrust Suit

    A neighborhood pharmacy in Chicago hit benefits manager Prime Therapeutics and Walgreens with a $1.5 billion antitrust suit in Illinois federal court on Thursday alleging they are working together to push the mom-and-pop shop out of the market through an anti-competitive agreement.